Dynavax Reports Positive Results
Dynavax Technologies Corp. (DVAX) reported positive results from its allergy drug treatment trial lifting the stock price $2.74 to close at $7.70.
posted by FC Market News at 2:33 PM
Thursday, October 05, 2006
Previous Posts
- Hott Topic's Sales Drop
- Helen Of Troy Beats Expectations
- Curis Receives $3 Million From Genentech
- Armor Holdings Slashes Outlook
- China Development In Compliance
- OM Group Lifts Outlook
- Sales Surge For Panera Bread
- Shaw Group Wins $12.8 Million Contract
- WCI Downgraded
- Quest Loses Contract
0 Comments:
Post a Comment
<< Home